speb/financial-data huggingface dataset:
SBIN.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 9137560796.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 9230671992.00
SBIN.NS income_statement (annual, 2026-03-31) — Diluted EPS: 91.16
SBIN.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 21.28
SBIN.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 832987824000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 196428700000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 99308997000.00
SBIN.NS cash_flow (annual, 2026-03-31) — End Cash Position: 4018432094000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -34271374000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Fixed Assets Revaluation Reserve: 344210301000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Fixed Assets Revaluation Reserve: 344210301000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 297344318000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 38194501000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: -23844050000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 73171000.00
SBIN.NS income_statement (annual, 2026-03-31) — Gain On Sale Of Security: 151091755000.00
SBIN.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 12110517000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Goodwill: 664056936000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 664056936000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 664056936000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 664056936000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 1024044914000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1024044914000.00
SBIN.NS income_statement (annual, 2026-03-31) — Insurance And Claims: 101247197000.00
SBIN.NS income_statement (annual, 2026-03-31) — Interest Expense: 3150048084000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 799534300000.00
SBIN.NS income_statement (annual, 2026-03-31) — Interest Income: 5149325904000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Interest Income: 1310801200000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -77217098000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 13230230898000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 13230230898000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -6908857000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 24179262558000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 24179262558000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Investments And Advances: 24303772616000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 24303772616000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Investmentsin Associatesat Cost: 2244738000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 2244738000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Investmentsin Subsidiariesat Cost: 122265320000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Subsidiariesat Cost: 122265320000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 249945335000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 137385000000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7268922204000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7268922204000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 137385000000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -196720000000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 124510058000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 124510058000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 187682823000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 187682823000.00
SBIN.NS income_statement (annual, 2026-03-31) — Minority Interests: -33668852000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -8651100000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 76711426000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 249945335000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Net Debt: 597787456000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 597787456000.00
SBIN.NS income_statement (annual, 2026-03-31) — Net Income: 832987824000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Net Income: 196428700000.00
SBIN.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 832987824000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 196428700000.00
SBIN.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 866656707000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 205079800000.00
SBIN.NS income_statement (annual, 2026-03-31) — Net Income Extraordinary: 0.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Net Income Extraordinary: 0.00
SBIN.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 832987824000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 196428700000.00
SBIN.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 832987824000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 196428700000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1121582973000.00
SBIN.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 866656707000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 205079800000.00
SBIN.NS income_statement (annual, 2026-03-31) — Net Interest Income: 1999277820000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: 511266900000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -59335000000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -59335000000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -5763152000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 9299000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Net PPE: 571521013000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 571521013000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -83629582000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 5297251758000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5297251758000.00
SBIN.NS income_statement (annual, 2026-03-31) — Normalized Income: 833043346154.80
SBIN.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 196428700000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 380973900000.00
SBIN.NS income_statement (annual, 2026-03-31) — Operating Revenue: 3817091770000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1011255900000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 9230617586.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 9230617586.00
SBIN.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 73972721000.00
SBIN.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1571160219000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 531992300000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Other Properties: 569935382000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 569935382000.00
SBIN.NS income_statement (annual, 2026-03-31) — Other Special Charges: 73171000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Payables: 441325736000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Payables: 441325736000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 362226591000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 362226591000.00
SBIN.NS income_statement (annual, 2026-03-31) — Pretax Income: 1140279817000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 260755100000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Properties: 447058134000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Properties: 447058134000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 215655780000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -1082683000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Receivables: 3673438505000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Receivables: 3673438505000.00
SBIN.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 48297185000.00
SBIN.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 70793171000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -196720000000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 1433820117000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1433820117000.00
SBIN.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 77794109000.00
SBIN.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 42466613000.00
SBIN.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 54577130000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Share Issued: 9230617586.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 9230617586.00
SBIN.NS income_statement (annual, 2026-03-31) — Special Income Charges: -73171000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 5961308694000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5961308694000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 5297251758000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5297251758000.00
SBIN.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -17648845.20
SBIN.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SBIN.NS income_statement (annual, 2026-03-31) — Tax Provision: 288595100000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 59142100000.00
SBIN.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.24
SBIN.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
SBIN.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -363229663000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Total Assets: 83215685742000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 83215685742000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 13230230898000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 13230230898000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Total Debt: 7268922204000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 7268922204000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 6148991517000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 6148991517000.00
SBIN.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 77066694225000.00
SBIN.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 77066694225000.00
SBIN.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -73171000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
SBIN.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -73171000.00
SBIN.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SBIO.V balance_sheet (annual, 2021-12-31) — Cash Financial: 3280335.00
SBIO.V cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
SBIO.V income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -62749.00
SBIO.V balance_sheet (annual, 2021-12-31) — Leases: 693229.00
SBIO.V cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
SBIO.V balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 0.00
SBIO.V balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 0.00
SBIO.V income_statement (annual, 2021-12-31) — Other Income Expense: 392511.00
SBIO.V income_statement (annual, 2021-12-31) — Other Special Charges: -2172500.00
SBIO.V balance_sheet (annual, 2021-12-31) — Prepaid Assets: 133091.00
SBIO.V cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
SBIO.V income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 1717240.00
SBIO.V income_statement (annual, 2022-12-31) — +Operating Expense: 25584602.00
SBIO.V income_statement (annual, 2022-12-31) — +Total Revenue: 42305732.00
SBIO.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 13022213.00
SBIO.V balance_sheet (annual, 2022-12-31) — Accounts Receivable: 12269474.00
SBIO.V balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -520978.00
SBIO.V balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -177626.00
SBIO.V income_statement (annual, 2022-12-31) — Amortization: 378043.00
SBIO.V cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 378043.00
SBIO.V cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 378043.00
SBIO.V income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 378043.00
SBIO.V income_statement (annual, 2022-12-31) — Basic Average Shares: 45222615.00
SBIO.V income_statement (annual, 2022-12-31) — Basic EPS: -0.02
SBIO.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 3280335.00
SBIO.V balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 2000228.00
SBIO.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -140130.00
SBIO.V balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1619337.00
SBIO.V balance_sheet (annual, 2022-12-31) — Capital Stock: 12068887.00
SBIO.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3999402.00
SBIO.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 3999402.00
SBIO.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 47916.00
SBIO.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1415033.00
SBIO.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 2086184.00
SBIO.V cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -233397.00
SBIO.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 5639021.00
SBIO.V cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -228524.00
SBIO.V cash_flow (annual, 2022-12-31) — Change In Receivables: -3892683.00
SBIO.V cash_flow (annual, 2022-12-31) — Change In Working Capital: 1284417.00
SBIO.V cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -3892683.00
SBIO.V cash_flow (annual, 2022-12-31) — Changes In Cash: 719067.00
SBIO.V balance_sheet (annual, 2022-12-31) — Common Stock: 12068887.00
SBIO.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2348054.00
SBIO.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 7770.00
SBIO.V income_statement (annual, 2022-12-31) — Cost Of Revenue: 16955141.00
SBIO.V balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 61520.00
SBIO.V balance_sheet (annual, 2022-12-31) — Current Assets: 17478554.00
SBIO.V balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 490664.00
SBIO.V balance_sheet (annual, 2022-12-31) — Current Debt: 3945423.00
SBIO.V balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 4436087.00
SBIO.V balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 276034.00
SBIO.V balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 276034.00
SBIO.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 17833811.00
SBIO.V cash_flow (annual, 2022-12-31) — Depreciation: 338489.00
SBIO.V cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 716532.00
SBIO.V income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 716532.00
SBIO.V cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 716532.00
SBIO.V income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 716532.00
SBIO.V income_statement (annual, 2022-12-31) — Depreciation Income Statement: 338489.00
SBIO.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 45222615.00
SBIO.V income_statement (annual, 2022-12-31) — Diluted EPS: -0.02
SBIO.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -846765.00
SBIO.V balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 848063.00
SBIO.V balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Non Current: 0.00
SBIO.V income_statement (annual, 2022-12-31) — EBIT: -390763.00
SBIO.V income_statement (annual, 2022-12-31) — EBITDA: 325769.00
SBIO.V cash_flow (annual, 2022-12-31) — End Cash Position: 3999402.00
SBIO.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: 47916.00
SBIO.V balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -104346.00
SBIO.V cash_flow (annual, 2022-12-31) — Free Cash Flow: 1946054.00
SBIO.V cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 24148.00
SBIO.V balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -104346.00
SBIO.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 6732092.00
SBIO.V balance_sheet (annual, 2022-12-31) — Goodwill: 2478774.00
SBIO.V balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 2832930.00
SBIO.V balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 12447100.00
SBIO.V balance_sheet (annual, 2022-12-31) — Gross PPE: 2000228.00
SBIO.V income_statement (annual, 2022-12-31) — Gross Profit: 25350591.00
SBIO.V balance_sheet (annual, 2022-12-31) — Income Tax Payable: 37957.00
SBIO.V income_statement (annual, 2022-12-31) — Interest Expense: 417362.00
SBIO.V income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 417362.00
SBIO.V balance_sheet (annual, 2022-12-31) — Interest Payable: 61520.00
SBIO.V balance_sheet (annual, 2022-12-31) — Invested Capital: 6772990.00
SBIO.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1415033.00
SBIO.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 7770.00
SBIO.V cash_flow (annual, 2022-12-31) — Issuance Of Debt: 298646.00
SBIO.V balance_sheet (annual, 2022-12-31) — Leases: 2000228.00
SBIO.V balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1128673.00
SBIO.V balance_sheet (annual, 2022-12-31) — Long Term Debt: 479513.00
SBIO.V balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1608186.00
SBIO.V cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 298646.00
SBIO.V cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -371708.00
SBIO.V cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1274903.00
SBIO.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 7770.00
SBIO.V balance_sheet (annual, 2022-12-31) — Net Debt: 425534.00
SBIO.V cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 1164.00
SBIO.V income_statement (annual, 2022-12-31) — Net Income: -846765.00
SBIO.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -846765.00
SBIO.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -846765.00
SBIO.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -846765.00
SBIO.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -846765.00
SBIO.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -846765.00
SBIO.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -846765.00
SBIO.V cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -140130.00
SBIO.V income_statement (annual, 2022-12-31) — Net Interest Income: -417362.00
SBIO.V cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -73062.00
SBIO.V cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -73062.00
SBIO.V income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -417362.00
SBIO.V cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -28547.00
SBIO.V balance_sheet (annual, 2022-12-31) — Net PPE: 1479250.00
SBIO.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -484876.00
SBIO.V balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 683.00
SBIO.V balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 683.00
SBIO.V balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 0.00
SBIO.V income_statement (annual, 2022-12-31) — Normalized EBITDA: 482521.00
SBIO.V income_statement (annual, 2022-12-31) — Normalized Income: -722930.92
SBIO.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: 2086184.00
SBIO.V cash_flow (annual, 2022-12-31) — Operating Gains Losses: 25312.00
SBIO.V income_statement (annual, 2022-12-31) — Operating Income: -234011.00
SBIO.V income_statement (annual, 2022-12-31) — Operating Revenue: 42305732.00
SBIO.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 46378188.00
SBIO.V balance_sheet (annual, 2022-12-31) — Other Current Assets: 361615.00
SBIO.V balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 3945423.00
SBIO.V balance_sheet (annual, 2022-12-31) — Other Equity Interest: 1438399.00
SBIO.V income_statement (annual, 2022-12-31) — Other Gand A: 5483584.00
SBIO.V income_statement (annual, 2022-12-31) — Other Income Expense: -156752.00
SBIO.V balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 354156.00
SBIO.V cash_flow (annual, 2022-12-31) — Other Non Cash Items: 149203.00
SBIO.V balance_sheet (annual, 2022-12-31) — Payables: 13060170.00
SBIO.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 13121690.00
SBIO.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 361615.00
SBIO.V income_statement (annual, 2022-12-31) — Pretax Income: -808125.00
SBIO.V cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 141755.00
SBIO.V balance_sheet (annual, 2022-12-31) — Properties: 0.00
SBIO.V cash_flow (annual, 2022-12-31) — Purchase Of Business: -1274903.00
SBIO.V cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -140130.00
SBIO.V balance_sheet (annual, 2022-12-31) — Receivables: 13117537.00
SBIO.V income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 16955141.00
SBIO.V income_statement (annual, 2022-12-31) — Reconciled Depreciation: 716532.00
SBIO.V income_statement (annual, 2022-12-31) — Rent And Landing Fees: 580786.00
SBIO.V income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 580786.00
SBIO.V cash_flow (annual, 2022-12-31) — Repayment Of Debt: -371708.00
SBIO.V income_statement (annual, 2022-12-31) — Research And Development: 5315656.00
SBIO.V income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 156752.00
SBIO.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -11054886.00
SBIO.V income_statement (annual, 2022-12-31) — Salaries And Wages: 667722.00
SBIO.V income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 12820322.00
SBIO.V income_statement (annual, 2022-12-31) — Selling General And Administration: 19552414.00
SBIO.V balance_sheet (annual, 2022-12-31) — Share Issued: 46378188.00
SBIO.V income_statement (annual, 2022-12-31) — Special Income Charges: -156752.00
SBIO.V cash_flow (annual, 2022-12-31) — Stock Based Compensation: 757485.00
SBIO.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2348054.00
SBIO.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: -484876.00
SBIO.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -32917.92
SBIO.V income_statement (annual, 2022-12-31) — Tax Provision: 38640.00
SBIO.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
SBIO.V balance_sheet (annual, 2022-12-31) — Total Assets: 21790734.00
SBIO.V balance_sheet (annual, 2022-12-31) — Total Capitalization: 2827567.00
SBIO.V balance_sheet (annual, 2022-12-31) — Total Debt: 6044273.00
SBIO.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2348054.00
SBIO.V income_statement (annual, 2022-12-31) — Total Expenses: 42539743.00
SBIO.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 19442680.00
SBIO.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 4312180.00
SBIO.V balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1608869.00
SBIO.V income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -234011.00
SBIO.V balance_sheet (annual, 2022-12-31) — Total Tax Payable: 37957.00
SBIO.V income_statement (annual, 2022-12-31) — Total Unusual Items: -156752.00
SBIO.V income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -156752.00
SBIO.V balance_sheet (annual, 2022-12-31) — Working Capital: -355257.00
SBIO.V income_statement (annual, 2023-12-31) — +Operating Expense: 25504143.00
SBIO.V income_statement (annual, 2023-12-31) — +Total Revenue: 35954934.00
SBIO.V balance_sheet (annual, 2023-12-31) — Accounts Payable: 9830189.00
SBIO.V balance_sheet (annual, 2023-12-31) — Accounts Receivable: 10831499.00
SBIO.V balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1126877.00
SBIO.V balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -65000.00
SBIO.V income_statement (annual, 2023-12-31) — Amortization: 162261.00
SBIO.V cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 162261.00
SBIO.V cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 162261.00
SBIO.V income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 162261.00
SBIO.V income_statement (annual, 2023-12-31) — Basic Average Shares: 48172524.00
SBIO.V income_statement (annual, 2023-12-31) — Basic EPS: -0.10
SBIO.V cash_flow (annual, 2023-12-31) — Beginning Cash Position: 3999402.00
SBIO.V balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 3319899.00
SBIO.V cash_flow (annual, 2023-12-31) — Capital Expenditure: -165746.00
SBIO.V balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2452897.00
SBIO.V balance_sheet (annual, 2023-12-31) — Capital Stock: 13074238.00
SBIO.V balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2612112.00
SBIO.V balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 2612112.00
SBIO.V balance_sheet (annual, 2023-12-31) — Cash Financial: 2612112.00
SBIO.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 3750655.00
SBIO.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -165746.00
SBIO.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -4972199.00
SBIO.V cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -259575.00
SBIO.V cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -3128761.00
SBIO.V cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -75256.00
SBIO.V cash_flow (annual, 2023-12-31) — Change In Receivables: 1437975.00
SBIO.V cash_flow (annual, 2023-12-31) — Change In Working Capital: -2025617.00
SBIO.V cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 1437975.00
SBIO.V cash_flow (annual, 2023-12-31) — Changes In Cash: -1387290.00
SBIO.V balance_sheet (annual, 2023-12-31) — Common Stock: 13074238.00
SBIO.V balance_sheet (annual, 2023-12-31) — Common Stock Equity: -1080717.00
SBIO.V cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
SBIO.V cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
SBIO.V income_statement (annual, 2023-12-31) — Cost Of Revenue: 14174632.00
SBIO.V balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 151275.00
SBIO.V balance_sheet (annual, 2023-12-31) — Current Assets: 14649163.00
SBIO.V balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 623786.00
SBIO.V balance_sheet (annual, 2023-12-31) — Current Debt: 7075392.00
SBIO.V balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 7699178.00
SBIO.V balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 16459.00
SBIO.V balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 16459.00
SBIO.V balance_sheet (annual, 2023-12-31) — Current Liabilities: 17744528.00
SBIO.V cash_flow (annual, 2023-12-31) — Depreciation: 605899.00
SBIO.V cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 768160.00
SBIO.V income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 768160.00
SBIO.V cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 768160.00
SBIO.V income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 768160.00
SBIO.V income_statement (annual, 2023-12-31) — Depreciation Income Statement: 605899.00
SBIO.V income_statement (annual, 2023-12-31) — Diluted Average Shares: 48172524.00
SBIO.V income_statement (annual, 2023-12-31) — Diluted EPS: -0.10
SBIO.V income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -4764536.00
SBIO.V balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 787107.00
SBIO.V balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Non Current: 90639.00
SBIO.V income_statement (annual, 2023-12-31) — EBIT: -3723841.00
SBIO.V income_statement (annual, 2023-12-31) — EBITDA: -2955681.00
SBIO.V cash_flow (annual, 2023-12-31) — End Cash Position: 2612112.00
SBIO.V cash_flow (annual, 2023-12-31) — Financing Cash Flow: 3750655.00
SBIO.V balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: -126602.00
SBIO.V cash_flow (annual, 2023-12-31) — Free Cash Flow: -5137945.00
SBIO.V cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 6612.00
SBIO.V balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -126602.00
SBIO.V income_statement (annual, 2023-12-31) — General And Administrative Expense: 6006334.00
SBIO.V balance_sheet (annual, 2023-12-31) — Goodwill: 2478774.00
SBIO.V balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 2829803.00
SBIO.V balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 10896499.00
SBIO.V balance_sheet (annual, 2023-12-31) — Gross PPE: 3319899.00
SBIO.V income_statement (annual, 2023-12-31) — Gross Profit: 21780302.00
SBIO.V balance_sheet (annual, 2023-12-31) — Income Tax Payable: 47427.00
SBIO.V income_statement (annual, 2023-12-31) — Interest Expense: 1049140.00
SBIO.V income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1049140.00
SBIO.V balance_sheet (annual, 2023-12-31) — Interest Payable: 151275.00
SBIO.V balance_sheet (annual, 2023-12-31) — Invested Capital: 7682776.00
SBIO.V cash_flow (annual, 2023-12-31) — Investing Cash Flow: -165746.00
SBIO.V cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
SBIO.V cash_flow (annual, 2023-12-31) — Issuance Of Debt: 4473266.00
SBIO.V balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
SBIO.V balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1829111.00
SBIO.V balance_sheet (annual, 2023-12-31) — Long Term Debt: 1688101.00
SBIO.V balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3517212.00
SBIO.V cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 4473266.00
SBIO.V cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -780059.00
SBIO.V cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
SBIO.V cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
SBIO.V balance_sheet (annual, 2023-12-31) — Net Debt: 6151381.00
SBIO.V cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -22256.00
SBIO.V income_statement (annual, 2023-12-31) — Net Income: -4764536.00
SBIO.V income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -4764536.00
SBIO.V income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -4764536.00
SBIO.V income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -4764536.00
SBIO.V income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -4764536.00
SBIO.V cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -4764536.00
SBIO.V income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -4764536.00
SBIO.V cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -165746.00
SBIO.V income_statement (annual, 2023-12-31) — Net Interest Income: -1049140.00
SBIO.V cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 3693207.00
SBIO.V cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 3693207.00
SBIO.V income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1049140.00
SBIO.V cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -600.00
SBIO.V balance_sheet (annual, 2023-12-31) — Net PPE: 2193022.00
SBIO.V cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 3234108.00
SBIO.V balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -3910520.00
SBIO.V balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 90639.00
SBIO.V balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 370.00
SBIO.V balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 370.00
SBIO.V balance_sheet (annual, 2023-12-31) — Non Current Note Receivables: 418766.00
SBIO.V income_statement (annual, 2023-12-31) — Normalized EBITDA: -2955681.00
SBIO.V income_statement (annual, 2023-12-31) — Normalized Income: -4764536.00
SBIO.V cash_flow (annual, 2023-12-31) — Operating Cash Flow: -4972199.00
SBIO.V cash_flow (annual, 2023-12-31) — Operating Gains Losses: -15644.00
SBIO.V income_statement (annual, 2023-12-31) — Operating Income: -3723841.00
SBIO.V income_statement (annual, 2023-12-31) — Operating Revenue: 35954934.00
SBIO.V balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 50070578.00
SBIO.V balance_sheet (annual, 2023-12-31) — Other Current Assets: 418445.00
SBIO.V balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 7075392.00
SBIO.V balance_sheet (annual, 2023-12-31) — Other Equity Interest: 1791069.00
SBIO.V income_statement (annual, 2023-12-31) — Other Gand A: 4628717.00
SBIO.V balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 351029.00
SBIO.V cash_flow (annual, 2023-12-31) — Other Non Cash Items: 293948.00
SBIO.V balance_sheet (annual, 2023-12-31) — Payables: 9877616.00
SBIO.V balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 10028891.00
SBIO.V income_statement (annual, 2023-12-31) — Pretax Income: -4772981.00
SBIO.V cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 58048.00
SBIO.V balance_sheet (annual, 2023-12-31) — Properties: 0.00
SBIO.V cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
SBIO.V cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -165746.00
SBIO.V balance_sheet (annual, 2023-12-31) — Receivables: 11618606.00
SBIO.V income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 14174632.00
SBIO.V income_statement (annual, 2023-12-31) — Reconciled Depreciation: 768160.00
SBIO.V income_statement (annual, 2023-12-31) — Rent And Landing Fees: 656332.00
SBIO.V income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 656332.00
SBIO.V cash_flow (annual, 2023-12-31) — Repayment Of Debt: -780059.00
SBIO.V cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
SBIO.V income_statement (annual, 2023-12-31) — Research And Development: 4698843.00
SBIO.V income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
SBIO.V balance_sheet (annual, 2023-12-31) — Retained Earnings: -15819422.00
SBIO.V income_statement (annual, 2023-12-31) — Salaries And Wages: 721285.00
SBIO.V income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 14030806.00
SBIO.V income_statement (annual, 2023-12-31) — Selling General And Administration: 20037140.00
SBIO.V balance_sheet (annual, 2023-12-31) — Share Issued: 50070578.00
SBIO.V income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
SBIO.V cash_flow (annual, 2023-12-31) — Stock Based Compensation: 771490.00
SBIO.V balance_sheet (annual, 2023-12-31) — Stockholders Equity: -1080717.00
SBIO.V balance_sheet (annual, 2023-12-31) — Tangible Book Value: -3910520.00
SBIO.V income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
SBIO.V income_statement (annual, 2023-12-31) — Tax Provision: -8445.00
SBIO.V income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
SBIO.V balance_sheet (annual, 2023-12-31) — Total Assets: 20181393.00
SBIO.V balance_sheet (annual, 2023-12-31) — Total Capitalization: 607384.00
SBIO.V balance_sheet (annual, 2023-12-31) — Total Debt: 11216390.00
SBIO.V balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -1080717.00
SBIO.V income_statement (annual, 2023-12-31) — Total Expenses: 39678775.00
SBIO.V balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 21262110.00
SBIO.V balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 5532230.00
SBIO.V balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 3517582.00
SBIO.V income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -3723841.00
SBIO.V balance_sheet (annual, 2023-12-31) — Total Tax Payable: 47427.00
SBIO.V income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
SBIO.V income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SBIO.V balance_sheet (annual, 2023-12-31) — Treasury Stock: 0.00
SBIO.V balance_sheet (annual, 2023-12-31) — Working Capital: -3095365.00
SBIO.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 50223072.00
SBIO.V income_statement (quarterly, 2024-09-30) — Basic EPS: 0.03
SBIO.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 50767877.00
SBIO.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.03
SBIO.V balance_sheet (quarterly, 2024-09-30) — Non Current Accounts Receivable: 30052.00
SBIO.V balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Liabilities: 370.00
SBIO.V balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 370.00
SBIO.V cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 2245.00
SBIO.V income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
SBIO.V income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: 2093321.00
SBIO.V income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
SBIO.V income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
SBIO.V balance_sheet (quarterly, 2024-09-30) — Treasury Stock: 796.00
SBIO.V income_statement (annual, 2024-12-31) — +Operating Expense: 28561571.00
SBIO.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 8911829.00
SBIO.V income_statement (annual, 2024-12-31) — +Total Revenue: 49602885.00
SBIO.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 18301162.00
SBIO.V balance_sheet (annual, 2024-12-31) — Accounts Payable: 15312299.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 15312299.00
SBIO.V balance_sheet (annual, 2024-12-31) — Accounts Receivable: 14732197.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 14732197.00
SBIO.V balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1816132.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1816132.00
SBIO.V balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -73613.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -73613.00
SBIO.V income_statement (annual, 2024-12-31) — Amortization: 193668.00
SBIO.V income_statement (quarterly, 2024-12-31) — Amortization: 45053.00
SBIO.V cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 193668.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 45053.00
SBIO.V cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 193668.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 45053.00
SBIO.V income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 193668.00
SBIO.V income_statement (quarterly, 2024-12-31) — Amortization Of Intangibles Income Statement: 45053.00
SBIO.V income_statement (annual, 2024-12-31) — Basic Average Shares: 50543985.00
SBIO.V income_statement (quarterly, 2024-12-31) — Basic Average Shares: 50543985.00
SBIO.V income_statement (annual, 2024-12-31) — Basic EPS: 0.00
SBIO.V income_statement (quarterly, 2024-12-31) — Basic EPS: 0.02
SBIO.V cash_flow (annual, 2024-12-31) — Beginning Cash Position: 2612112.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 2871886.00
SBIO.V balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 3168025.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 3168025.00
SBIO.V cash_flow (annual, 2024-12-31) — Capital Expenditure: -102861.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -27343.00
SBIO.V balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1713224.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 1713224.00
SBIO.V balance_sheet (annual, 2024-12-31) — Capital Stock: 13307749.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 13307749.00
SBIO.V balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 3300439.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 3300439.00
SBIO.V balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3300439.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3300439.00
SBIO.V balance_sheet (annual, 2024-12-31) — Cash Financial: 3300439.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Cash Financial: 3300439.00
SBIO.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -2981841.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -662523.00
SBIO.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -102861.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -27343.00
SBIO.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 3773029.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: 1118419.00
SBIO.V cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 25745.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -94609.00
SBIO.V cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 5441893.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 2673818.00
SBIO.V cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -18665.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 165529.00
SBIO.V cash_flow (annual, 2024-12-31) — Change In Receivables: -3900698.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: -4050572.00
SBIO.V cash_flow (annual, 2024-12-31) — Change In Working Capital: 1548275.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -1305834.00
SBIO.V cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -3900698.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -4050572.00
SBIO.V cash_flow (annual, 2024-12-31) — Changes In Cash: 688327.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: 428553.00
SBIO.V balance_sheet (annual, 2024-12-31) — Common Stock: 13307749.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 13307749.00
SBIO.V balance_sheet (annual, 2024-12-31) — Common Stock Equity: -971647.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -971647.00
SBIO.V cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
SBIO.V cash_flow (annual, 2024-12-31) — Common Stock Payments: -13560.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -12764.00
SBIO.V income_statement (annual, 2024-12-31) — Cost Of Revenue: 18975496.00
SBIO.V income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 7014407.00
SBIO.V balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 112280.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 112280.00
SBIO.V balance_sheet (annual, 2024-12-31) — Current Assets: 18576624.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 18576624.00
SBIO.V balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 448882.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 448882.00
SBIO.V balance_sheet (annual, 2024-12-31) — Current Debt: 6415377.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Current Debt: 6415377.00
SBIO.V balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 6864259.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 6864259.00
SBIO.V balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 42204.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 42204.00
SBIO.V balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 42204.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 42204.00
SBIO.V balance_sheet (annual, 2024-12-31) — Current Liabilities: 22377617.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 22377617.00
SBIO.V balance_sheet (annual, 2024-12-31) — Current Notes Payable: 0.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 0.00
SBIO.V cash_flow (annual, 2024-12-31) — Depreciation: 689255.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Depreciation: 148627.00
SBIO.V cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 882923.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 193680.00
SBIO.V income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 882923.00
SBIO.V income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 193680.00
SBIO.V cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 882923.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 193680.00
SBIO.V income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 882923.00
SBIO.V income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 193680.00
SBIO.V income_statement (annual, 2024-12-31) — Depreciation Income Statement: 689255.00
SBIO.V income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 148627.00
SBIO.V income_statement (annual, 2024-12-31) — Diluted Average Shares: 50543985.00
SBIO.V income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 50543985.00
SBIO.V income_statement (annual, 2024-12-31) — Diluted EPS: 0.00
SBIO.V income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.02
SBIO.V income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -110875.00
SBIO.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 1194528.00
SBIO.V balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 62156.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Current: 62156.00
SBIO.V balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Non Current: 28755.00